Stay updated on IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib

Sign up to get notified when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.
Latest website image capture
Clouds background image

Latest updates to the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page

  1. Check
    yesterday
    Change Detected
    Summary
    Both screenshots show the same study details with no changes to core information such as title, conditions, interventions, eligibility criteria, enrollment numbers, or primary outcomes; only minor formatting adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T13:13:03.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    Major updates: added government operating status notice and new research citation; updated version to v3.2.0, replacing the previous v3.0.2.
    Difference
    2%
    Check dated 2025-10-02T01:24:55.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Page version updated to v3.1.0 and a new 2025 citation added; previous version v3.0.2 removed.
    Difference
    0.6%
    Check dated 2025-09-30T14:27:05.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 replacing v3.0.1, indicating a new release. The 'Back to Top' element has been removed, suggesting a minor UI cleanup.
    Difference
    0.1%
    Check dated 2025-09-16T05:38:17.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-09T01:12:18.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of various facility names and locations across multiple countries, while also removing several previous location entries and terms. Notably, the revision number has been updated from v2.16.12 to v3.0.0.
    Difference
    8%
    Check dated 2025-09-01T21:03:14.000Z thumbnail image

Stay in the know with updates to IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib

Enter your email address, and we'll notify you when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.